Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic ASIT for Pollen-induced Allergic Rhinitis
NCT02423707Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Aug 2010
- Primary completion
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Alutard SQ Birch, ALK Alutard 5-grasses in allergic rhinitis (AR), sponsored by Karolinska Institutet. Started Aug 2010; status: completed.
02
Drugs
Alutard SQ BirchALK Alutard 5-grasses
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02423707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423707.